Document is current
Any future updates will be listed below
-
Authors
Taavela, Juha
Viiri, Keijo
Popp, Alina
Oittinen, Mikko
Dotsenko, Valeriia
Peräaho, Markku
Staff, Synnöve
Sarin, Jani
Leon, Francisco
Mäki, Markku
Isola, Jorma
-
Funding
Funding for this research was provided by:
Academy of Finland (310011)
Tekes (658/31/2015)
Paediatric Research Foundation (-)
Sigrid Jusélius Foundation (-)
Competitive State Research Financing of the Expert Responsibility Area of Tampere University Hospital (9V041 and 9X035)
- License Information
-
More Information
Article History
Received: 14 May 2019
Accepted: 7 October 2019
First Online: 15 November 2019
Ethics approval and consent to participate
: The study subjects gave their voluntary, informed, written consent to perform the study. The study was approved by the Ethics Committee of the Tampere University Hospital District, Tampere, Finland (ETL-code R15185M). The study was performed according to the principles of the Helsinki Declaration of the World Medical Association.
: Not applicable.
: JI is the chief execute officer of Jilab Inc. that produces diagnostic laboratory services for small-bowel diseases and a wide variety of cancers. JS is an employee of Jilab Inc.
